Anthony S Marucci is PRESIDENT & CEO of Celldex Therapeutics, Inc.. Currently has a direct ownership of 40,284 shares of CLDX, which is worth approximately $1.06 Million. The most recent transaction as insider was on Nov 11, 2024, when has been sold 11,500 shares (Common Stock) at a price of $26.82 per share, resulting in proceeds of $308,430. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.3K
45.47% 3M change
45.47% 12M change
Total Value Held $1.06 Million

Anthony S Marucci Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 11 2024
BUY
Open market or private purchase
$308,430 $26.82 p/Share
11,500 Added 22.21%
40,284 Common Stock
Aug 15 2022
SELL
Open market or private sale
$4,519,200 $37.66 p/Share
120,000 Reduced 81.25%
27,692 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$708,000 $5.9 p/Share
120,000 Added 44.83%
147,692 Common Stock
Aug 05 2021
BUY
Exercise of conversion of derivative security
$148,554 $42.0 p/Share
3,537 Added 11.5%
27,231 Common Stock
ASM

Anthony S Marucci

PRESIDENT & CEO
Hampton, NJ

Track Institutional and Insider Activities on CLDX

Follow Celldex Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLDX shares.

Notify only if

Insider Trading

Get notified when an Celldex Therapeutics, Inc. insider buys or sells CLDX shares.

Notify only if

News

Receive news related to Celldex Therapeutics, Inc.

Track Activities on CLDX